GB201903799D0 - Compounds for treatment of prostate cancer - Google Patents

Compounds for treatment of prostate cancer

Info

Publication number
GB201903799D0
GB201903799D0 GBGB1903799.3A GB201903799A GB201903799D0 GB 201903799 D0 GB201903799 D0 GB 201903799D0 GB 201903799 A GB201903799 A GB 201903799A GB 201903799 D0 GB201903799 D0 GB 201903799D0
Authority
GB
United Kingdom
Prior art keywords
compounds
treatment
prostate cancer
prostate
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1903799.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Katholieke Universiteit Leuven
Original Assignee
Katholieke Universiteit Leuven
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Katholieke Universiteit Leuven filed Critical Katholieke Universiteit Leuven
Priority to GBGB1903799.3A priority Critical patent/GB201903799D0/en
Publication of GB201903799D0 publication Critical patent/GB201903799D0/en
Ceased legal-status Critical Current

Links

GBGB1903799.3A 2019-03-20 2019-03-20 Compounds for treatment of prostate cancer Ceased GB201903799D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1903799.3A GB201903799D0 (en) 2019-03-20 2019-03-20 Compounds for treatment of prostate cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1903799.3A GB201903799D0 (en) 2019-03-20 2019-03-20 Compounds for treatment of prostate cancer

Publications (1)

Publication Number Publication Date
GB201903799D0 true GB201903799D0 (en) 2019-05-01

Family

ID=66381029

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1903799.3A Ceased GB201903799D0 (en) 2019-03-20 2019-03-20 Compounds for treatment of prostate cancer

Country Status (1)

Country Link
GB (1) GB201903799D0 (en)

Similar Documents

Publication Publication Date Title
ZA202206743B (en) Therapy for the treatment of cancer
IL285807A (en) Immunotherapy for the treatment of cancer
SG11202011117VA (en) Treatment of cancer
SG11202010793UA (en) Methods of treating cancer
EP4010081A4 (en) Combination therapy for treatment of cancer
IL281845A (en) Combination therapy for the treatment of cancer
IL284162A (en) Combination therapy for the treatment of cancer
SG11202107017TA (en) Methods of treating cancer
IL288522A (en) Egfr inhibitor for the treatment of cancer
IL289811A (en) Method of treating cancer
IL281281A (en) Combination therapy for the treatment of prostate cancer
IL281600A (en) Methods of treating cancer
IL277981A (en) Methods of treating cancer
EP3947460A4 (en) Multispecific agents for treatment of cancer
GB201909468D0 (en) Compounds for treating cancer
IL289201A (en) Compounds for treatment of cancer
EP3793548A4 (en) Compounds for treatment of pancreatic cancer
IL286353A (en) Combinations of iadademstat for cancer therapy
GB201903799D0 (en) Compounds for treatment of prostate cancer
PL3630754T3 (en) Isoindoline-acetylene compounds for the treatment of cancer
IL290038A (en) Focal treatment of prostate cancer
GB201918815D0 (en) Treatment of cancer
IL308088A (en) Masitinib for the treatment of castrate-resistant prostate cancer
IL305780A (en) Methods for the treatment of cancer
EP3962921A4 (en) Coumarin-modified androgens for the treatment of prostate cancer

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)